Molecular profiling of frontal and occipital subcortical white matter hyperintensities in Alzheimer's disease

Sulochan Malla1,2, Annie G Bryant1,3, Rojashree Jayakumar1

  • 1Department of Neurology, Massachusetts General Hospital, Charlestown, MA, United States.

Frontiers in Neurology
|January 23, 2025
PubMed

Insights

Alzheimer's disease (AD) white matter changes involve vascular and protein folding pathways. Immune function pathways are elevated in individuals with higher white matter hyperintensities (WMH) burden.

Area of Science:

  • Neuroscience
  • Genomics
  • Pathology

Background:

  • White matter hyperintensities (WMHs) are common in aging and Alzheimer's disease (AD).
  • WMHs are linked to cognitive decline in AD, but their molecular drivers are unknown.
  • Understanding WMH molecular mechanisms is crucial for AD research.

Purpose of the Study:

  • To investigate the transcriptomic profiles of white matter in AD.
  • To identify molecular factors contributing to WMHs in AD.
  • To compare gene expression in affected brain regions between AD patients and controls.

Main Methods:

  • RNA sequencing of bulk frontal and occipital white matter (WM) tissues.
  • RNA sequencing of isolated blood vessels from WM.
  • Comparison of gene expression between AD individuals with high and low WMH burden.

Main Results:

  • Upregulation of brain vasculature function genes in AD white matter.
  • Upregulation of protein folding pathway genes in isolated AD WM blood vessels.
  • Increased immune function pathways in AD individuals with high WMH burden.

Conclusions:

  • AD white matter exhibits distinct transcriptomic profiles.
  • Vascular and protein folding pathways are implicated in AD-related WMHs.
  • Immune responses correlate with WMH severity in AD.